CCAP Jason Breaux bought Crescent Capital BDC, Inc. shares — SEC Form 4BUYCrescent Capital BDC, Inc.

The stock has underperformed recently, falling 4.92% over the past five days and 15.48% over the last month to trade at $11.41, which is 28.84% below its 52-week high of $16.04.

• •2 other insiders bought in the last 30 days, indicating a growing insider consensus on the stock's value.
• •Keefe Bruyette lowered the price target to $15 on May 5, reaffirming an Outperform rating, which could provide a floor for the stock.

• •Management recently lowered fees and reset the base dividend due to higher non-accruals and lower base rates, which could compress future income generation.
• •Additionally, the stock trades at a high trailing P/E of 28.6 compared to a forward P/E of 7.67, suggesting potential overvaluation relative to near-term earnings.